Certified by Founder Lodge
Camena Bioscience
United Kingdom - Cambridge
START UP
1 Disclosed Funding Rounds $9,901,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy.
We produce genes for a range of biotechnology customers includ
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 04 ,2023 | Series A | $9,901,000 |
Mercia Asset Management PLC
ChromaCode, Inc.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
